Phase 2 Obesity Trial New England Journal of Medicine (2023) The pivotal Phase 2 obesity trial of retatrutide, published in the New England Journal of Medicine, enrolled 338 adults with obesity (BMI 30) or overweight with weight-related comorbidities
6 The MHRA has also warned that Mounjaro may reduce the effectiveness of the combined oral contraceptive pill
Read the pricing guide When does paying out of pocket first make sense
Practical implications for compounded GLP-1: state boards of pharmacy and the FDA are paying closer attention to the entire 503A space
Urgent care can effectively diagnose most hernias through physical examination, but severe pain, nausea, or inability to reduce the bulge requires immediate emergency care
Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A